Opportunity Information: Apply for CDC RFA GH14 1415
Apply for CDC RFA GH14 1415
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 6, 2014 and posted on Mar 6, 2014.
- Applicants must submit their applications by Apr 21, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $30,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $7,600,000.00 in funding.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) is a PEPFAR-funded cooperative agreement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC). The opportunity is designed to support Namibia's national HIV response by pairing CDC technical leadership with on-the-ground partners to deliver targeted public health assistance that fits within Namibia's own strategic plans and partnership framework. In practical terms, it is meant to strengthen systems and services that prevent new HIV infections, improve clinical outcomes for people living with HIV, and build durable national capacity in surveillance, laboratories, and program management. Because it is a cooperative agreement, applicants should expect substantial CDC involvement in technical direction, coordination, and performance monitoring, rather than a hands-off grant model.
The program is organized around four main priority areas that reflect CDC's core public health approach within PEPFAR. First, it emphasizes primary prevention of HIV infection, including expanding confidential counseling and testing services that are linked to evidence-based behavioral interventions, and strengthening programs aimed at preventing mother-to-child transmission. Second, it prioritizes improving care and treatment for HIV/AIDS and related conditions, with a strong focus on sexually transmitted infection management, laboratory diagnostic capacity, and better prevention and treatment of opportunistic infections. This area explicitly includes integrated responses to diseases that complicate HIV outcomes, especially tuberculosis, and it supports the initiation and scale-up of antiretroviral therapy programs. Third, the opportunity centers on strengthening national capacity to collect, analyze, and use surveillance data, and to manage national HIV/AIDS programs more effectively. This includes expanding HIV, STI, and TB surveillance platforms and reinforcing laboratory systems that support surveillance, diagnosis, treatment decision-making, disease monitoring, and blood safety screening. Fourth, it supports the development, validation, and evaluation of public health programs so Namibia and its partners can generate evidence on what works, improve program quality, and better target prevention and treatment interventions across HIV, TB, and opportunistic infections.
The funding announcement (CDC RFA GH14-1415) was posted March 6, 2014, with an application closing date of April 21, 2014, and an estimated total funding level of $30,000,000. CDC anticipated making up to 8 awards under this announcement. The stated award ceiling is $7,600,000 (with an award floor of $0), and there is no cost-sharing or matching requirement. A key detail is that the first budget period is structured as an 18-month "Year 1," with specific ceiling amounts tied to program areas: Program Area 1 up to $1,000,000; Program Area 2 up to $7,600,000; Program Area 3 up to $2,000,000; and Program Area 4 up to $400,000. This breakout signals that the largest expected investments were aligned with the second program area, which focuses on improving care and treatment systems, including ART-related scale-up and clinical and laboratory strengthening.
Eligibility is broad and includes a wide range of domestic and non-domestic entities. Eligible applicants include nonprofit organizations with or without 501(c)(3) status, for-profit entities (including small, minority-, and women-owned businesses), universities, colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal health organizations, tribal epidemiology centers, and state/local governments or their bona fide agents. The announcement also allows non-U.S. entities to apply, which is particularly relevant for in-country implementers and regional technical partners. Applicants applying as a bona fide agent for a state or local government are required to provide a legal, binding agreement documenting that status as part of the application package.
Overall, NAM PHACTS is best understood as a platform for CDC-supported technical assistance and capacity building that strengthens Namibia's HIV prevention, treatment, laboratory, surveillance, and evaluation systems under PEPFAR. The intent is not only to deliver services, but also to improve how national programs function by building data-driven decision-making, stronger diagnostic and monitoring infrastructure, integrated HIV/TB approaches, and continuous program learning so interventions can be refined and scaled effectively over time.
FAQs: Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS) - CDC RFA GH14-1415
What is NAM PHACTS?
NAM PHACTS (Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support) is a PEPFAR-funded cooperative agreement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC). It is designed to support Namibia's national HIV response through targeted public health assistance and capacity strengthening aligned with Namibia's strategic plans and partnership framework.
Who is funding and administering this opportunity?
The opportunity is funded through PEPFAR and administered by HHS/CDC.
What type of award is this?
This is a cooperative agreement. That means applicants should expect substantial CDC involvement in technical direction, coordination, and performance monitoring, rather than a hands-off grant model.
What is the overall purpose of the program?
The program aims to strengthen systems and services that prevent new HIV infections, improve clinical outcomes for people living with HIV, and build durable national capacity in areas such as surveillance, laboratories, and program management.
How does this opportunity fit within Namibia's national plans?
The opportunity is intended to deliver public health assistance that fits within Namibia's own strategic plans and partnership framework, rather than operating as a standalone effort.
What are the main priority areas under NAM PHACTS?
The program is organized around four main priority areas:
- Primary prevention of HIV infection
- Improving care and treatment for HIV/AIDS and related conditions
- Strengthening national surveillance and program management capacity
- Developing, validating, and evaluating public health programs
What is included in Priority Area 1 (primary prevention)?
Priority Area 1 emphasizes primary prevention of HIV infection, including expanding confidential counseling and testing services linked to evidence-based behavioral interventions, and strengthening programs aimed at preventing mother-to-child transmission.
What is included in Priority Area 2 (care and treatment improvement)?
Priority Area 2 focuses on improving care and treatment for HIV/AIDS and related conditions. It highlights sexually transmitted infection (STI) management, laboratory diagnostic capacity, and improved prevention and treatment of opportunistic infections. It also includes integrated responses to diseases that complicate HIV outcomes, especially tuberculosis, and supports the initiation and scale-up of antiretroviral therapy (ART) programs.
What is included in Priority Area 3 (surveillance and program management capacity)?
Priority Area 3 centers on strengthening national capacity to collect, analyze, and use surveillance data and to manage national HIV/AIDS programs more effectively. It includes expanding HIV, STI, and TB surveillance platforms and reinforcing laboratory systems that support surveillance, diagnosis, treatment decision-making, disease monitoring, and blood safety screening.
What is included in Priority Area 4 (program development and evaluation)?
Priority Area 4 supports the development, validation, and evaluation of public health programs so that Namibia and its partners can generate evidence on what works, improve program quality, and better target prevention and treatment interventions across HIV, TB, and opportunistic infections.
Does the program address tuberculosis (TB) as part of the HIV response?
Yes. The opportunity explicitly includes integrated responses to diseases that complicate HIV outcomes, especially tuberculosis, and supports surveillance and program approaches that span HIV, TB, and opportunistic infections.
Does the program support antiretroviral therapy (ART) scale-up?
Yes. Priority Area 2 specifically supports the initiation and scale-up of antiretroviral therapy programs as part of improving care and treatment systems.
Is laboratory strengthening part of this opportunity?
Yes. Laboratory capacity is emphasized, including diagnostic capacity, laboratory systems that support surveillance and treatment decision-making, disease monitoring, and blood safety screening.
Is surveillance strengthening part of this opportunity?
Yes. Strengthening the collection, analysis, and use of surveillance data is a core component, including expansion of HIV, STI, and TB surveillance platforms.
What is the funding announcement number and title?
The funding announcement is CDC RFA GH14-1415, titled the Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM PHACTS).
When was this announcement posted and when did it close?
The announcement was posted on March 6, 2014, and the application closing date was April 21, 2014.
What is the estimated total funding level?
The estimated total funding level stated in the announcement is $30,000,000.
How many awards did CDC anticipate making?
CDC anticipated making up to 8 awards under this announcement.
What is the award ceiling and award floor?
The stated award ceiling is $7,600,000, and the award floor is $0.
Is there a cost-sharing or matching requirement?
No. The announcement states there is no cost-sharing or matching requirement.
How is the first budget period structured?
The first budget period is structured as an 18-month "Year 1."
Are there program-area-specific funding ceilings for the first 18-month budget period?
Yes. The "Year 1" ceilings are tied to the program areas as follows: Program Area 1 up to $1,000,000; Program Area 2 up to $7,600,000; Program Area 3 up to $2,000,000; and Program Area 4 up to $400,000.
Which program area appears to receive the largest expected investment?
The largest ceiling is aligned with Program Area 2 (up to $7,600,000), signaling the largest expected investments were directed toward improving care and treatment systems, including ART-related scale-up and clinical and laboratory strengthening.
Who is eligible to apply?
Eligibility is broad and includes domestic and non-domestic entities. Eligible applicants include nonprofit organizations (with or without 501(c)(3) status), for-profit entities (including small, minority-, and women-owned businesses), universities, colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal health organizations, tribal epidemiology centers, and state/local governments or their bona fide agents.
Are non-U.S. entities eligible to apply?
Yes. The announcement allows non-U.S. entities to apply, which can be relevant for in-country implementers and regional technical partners.
What is required if applying as a bona fide agent for a state or local government?
Applicants applying as a bona fide agent for a state or local government must provide a legal, binding agreement documenting that status as part of the application package.
Is this opportunity intended only for direct service delivery?
No. While service strengthening is part of the intent, NAM PHACTS is described as a platform for CDC-supported technical assistance and capacity building. The goal is also to improve how national programs function through stronger data-driven decision-making, diagnostic and monitoring infrastructure, integrated HIV/TB approaches, and continuous program learning.
What does "substantial CDC involvement" mean in practice for applicants?
Based on the cooperative agreement description, applicants should plan for CDC technical leadership to be closely involved in technical direction, coordination with partners, and performance monitoring throughout implementation.
What kinds of systems are meant to be strengthened through this award?
The opportunity emphasizes strengthening prevention and treatment systems, laboratory and diagnostic systems, surveillance platforms, program management capacity, and evaluation functions to support continuous improvement and scale-up over time.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Avian Monitoring for Listed And Species At Risk at Naval Air Weapons Station China Lake, China Lake, California
Previous opportunity: Discovery, validation, and genotyping of single nucleotide polymorphisms in Pacific walrus (Odobenus rosmarus divergens)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH14 1415
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH14 1415) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Grants for Alzheimers Disease Translational Centers for Predictive Drug Development (R34) Apply for RFA AG 14 017 Funding Number: RFA AG 14 017 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| RFI National and Local Government Authority Health Systems Strengthening Apply for RFI HHS TANZANIA Funding Number: RFI HHS TANZANIA Agency: Agency for International Development Category: Health Funding Amount: $74,999,999 |
| Pediatric Environmental Health Specialty Unit (PEHSU) Program Apply for CDC RFA TS14 1402 Funding Number: CDC RFA TS14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Free Communities Mentoring Program Apply for SP 14 003 Funding Number: SP 14 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $75,000 |
| FY14 Announcement of Availability of Funds for Family Planning Affordable Care Act (ACA) Impact Analysis Research Cooperative Agreements Apply for PA FPR 14 002 Funding Number: PA FPR 14 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $400,000 |
| PROJECT SOAR Apply for RFA OAA 14 00026 Funding Number: RFA OAA 14 00026 Agency: Agency for International Development Category: Health Funding Amount: $70,000,000 |
| Evidence Based Labortatory Medicine Labortatory Medicine Best Practices Systematic Review Recommendation Evaluation, CSELS and DLPSS Apply for CDC RFA OE13 130302CONT14 Funding Number: CDC RFA OE13 130302CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements to Benefit Homeless Individuals States Supplement (Short Title CABHI States Supplement) Apply for SM 14 012 Funding Number: SM 14 012 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $499,351 |
| Collaboration for Improving Promoting Standardized Cancer Staging Using the Collaborative Stage Data Collection System Apply for CDC RFA DP13 131002CONT14 Funding Number: CDC RFA DP13 131002CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Evaluation of AHRQ Initiative to Accelerate the Dissemination and Implementation of PCOR Findings into Primary Care (R01) Apply for RFA HS 14 009 Funding Number: RFA HS 14 009 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Accelerating the Dissemination and Implementation of PCOR Findings into Primary Care Practice (R18) Apply for RFA HS 14 008 Funding Number: RFA HS 14 008 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Act Against AIDS Leadership Initiative Apply for CDC RFA PS10 105705CONT14 Funding Number: CDC RFA PS10 105705CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Comprehensive Asthma Control Through Evidence based Strategies and Public HealthHealth Care Collaboration Apply for CDC RFA EH14 1404 Funding Number: CDC RFA EH14 1404 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Partnerships for Diagnostics to Address Antimicrobial Resistance of Select Bacterial Pathogens (R01) Apply for RFA AI 14 019 Funding Number: RFA AI 14 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| To Strengthen Collaboration between CDC and the National TB Controller and the National TB Nurse Coalition Apply for CDC RFA PS12 120503CONT14 Funding Number: CDC RFA PS12 120503CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY14 Announcement of Availability of Funds for Embryo Donation and/or Adoption Grant Projects Apply for PA EAA 14 002 Funding Number: PA EAA 14 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| Public Health Systems Capacity Building in Central Asia Apply for CDC RFA GH14 1417 Funding Number: CDC RFA GH14 1417 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| R40 MCH Autism Intervention Research Program Apply for HRSA 14 037 Funding Number: HRSA 14 037 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 MCH Autism Secondary Data Analysis Studies (SDAS) Program Apply for HRSA 14 125 Funding Number: HRSA 14 125 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| R40 MCH Autism Longitudinal Data Project Apply for HRSA 14 127 Funding Number: HRSA 14 127 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH14 1415", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.